Transcriptomics- and machine learning-based identification and mechanistic in vitro validation of a cardiovascular risk gene signature at the CKD–cancer intersection: a multi-omics approach

Chongze Lin, Sisi Shao, Meizi Xia, Shourong Lu · 2026

Read Transcriptomics- and machine learning-based identification and mechanistic in vitro validation of a cardiovascular risk gene signature at the CKD–cancer intersection: a multi-omics approach by Chongze Lin, Sisi Shao, Meizi Xia, Shourong Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616729.txt.

Description

Chongze Lin and co-authors hunt gene signatures for heart risk where kidney disease and cancer meet, in this 2026 study. Cancer drugs can injure the heart, and patients on dialysis carry extra risk from their uraemic blood chemistry, polypharmacy, and the treatments themselves. No gene-based, machine-learned model validated in that toxic milieu existed for this crossroads population. The team combined gene-activity data with learning algorithms to nominate a signature.

Bench experiments in cells then tested whether the nominated genes truly move the relevant biology. A validated signature could flag, before treatment, which kidney patients face the steepest heart risk from a cancer drug. Cardio-oncology needs such early warnings most exactly where risks stack highest.

Catalog record

CREATORChongze Lin, Sisi Shao, Meizi Xia, Shourong Lu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13616729

Browse the full library · About the Tower of Babel